| Primary |
| Product Used For Unknown Indication |
39.8% |
| Enterobiasis |
13.9% |
| Drug Use For Unknown Indication |
6.1% |
| Helminthic Infection |
5.6% |
| Drug Exposure During Pregnancy |
4.3% |
| Foetal Exposure During Pregnancy |
3.9% |
| Prophylaxis |
3.5% |
| Ascariasis |
2.6% |
| Self Injurious Behaviour |
2.6% |
| Suicidal Ideation |
2.6% |
| Echinococciasis |
2.2% |
| Hepatic Echinococciasis |
2.2% |
| Nematodiasis |
2.2% |
| Parasitic Gastroenteritis |
2.2% |
| Gastrointestinal Infection |
1.3% |
| Infection |
1.3% |
| Infection Parasitic |
1.3% |
| Cestode Infection |
0.9% |
| Contraception |
0.9% |
| Headache |
0.9% |
|
| Self Injurious Behaviour |
10.9% |
| Drug Exposure During Pregnancy |
7.8% |
| Urticaria |
7.8% |
| Vomiting |
7.8% |
| Foetal Exposure During Pregnancy |
6.3% |
| Dizziness |
4.7% |
| Haemangioma Congenital |
4.7% |
| Hypospadias |
4.7% |
| Pruritus |
4.7% |
| Pyrexia |
4.7% |
| Talipes |
4.7% |
| Tearfulness |
4.7% |
| Trisomy 21 |
4.7% |
| Cytolytic Hepatitis |
3.1% |
| Glomerulonephritis Membranous |
3.1% |
| Haematochezia |
3.1% |
| Henoch-schonlein Purpura |
3.1% |
| Infertility Female |
3.1% |
| Intra-uterine Death |
3.1% |
| Muscle Spasms |
3.1% |
|
| Secondary |
| Self Injurious Behaviour |
42.2% |
| Intentional Self-injury |
11.9% |
| Enterobiasis |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Hepatic Echinococciasis |
5.2% |
| Overdose |
4.4% |
| Maternal Exposure Timing Unspecified |
3.7% |
| Ascariasis |
3.0% |
| Proctitis |
3.0% |
| Echinococciasis |
2.2% |
| Worms |
2.2% |
| Blood Disorder |
1.5% |
| Herpes Virus Infection |
1.5% |
| Pulmonary Echinococciasis |
1.5% |
| Anti-infective Therapy |
0.7% |
| Blood Disorder Nos |
0.7% |
| Cystitis |
0.7% |
| Helminthic Infection |
0.7% |
| Hookworm Infection |
0.7% |
| Infection Parasitic |
0.7% |
|
| Self Injurious Behaviour |
17.1% |
| Cytolytic Hepatitis |
14.3% |
| Pharyngeal Erythema |
8.6% |
| Tearfulness |
8.6% |
| Premature Baby |
5.7% |
| Pyrexia |
5.7% |
| Condition Aggravated |
2.9% |
| Dizziness |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Eosinophilic Colitis |
2.9% |
| Granulomatous Liver Disease |
2.9% |
| Hypospadias |
2.9% |
| Intentional Self-injury |
2.9% |
| Intra-uterine Death |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Medication Error |
2.9% |
| Oropharyngeal Pain |
2.9% |
| Rash Generalised |
2.9% |
| Respiratory Tract Infection |
2.9% |
| Skin Exfoliation |
2.9% |
|
| Concomitant |
| Asthma |
27.6% |
| Rhinitis Allergic |
13.8% |
| Arthritis |
10.3% |
| Drug Use For Unknown Indication |
10.3% |
| Arthralgia |
6.9% |
| Enterobiasis |
6.9% |
| Infection Parasitic |
6.9% |
| Crohn's Disease |
3.4% |
| Relapsing-remitting Multiple Sclerosis |
3.4% |
| Toxocariasis |
3.4% |
| Urinary Tract Infection |
3.4% |
| Ventricular Dysfunction |
3.4% |
|
| Drug Ineffective |
13.3% |
| Eosinophilic Oesophagitis |
13.3% |
| Myocardial Infarction |
13.3% |
| Cerebrovascular Accident |
6.7% |
| Drug Dose Omission |
6.7% |
| Gastritis |
6.7% |
| Gastrooesophageal Reflux Disease |
6.7% |
| Influenza |
6.7% |
| Pain |
6.7% |
| Sensory Loss |
6.7% |
| Tricuspid Valve Incompetence |
6.7% |
| Vomiting |
6.7% |
|
